Vitiligo develops when your immune system mistakenly attacks and destroys the cells that produce skin pigment, called melanocytes. This process leaves behind smooth, white patches on the skin that can appear anywhere on the body. About 0.36% of the global population has been diagnosed with vitiligo, roughly 28.5 million people, and the condition affects both adults and children across all skin tones.
The short answer is that vitiligo isn’t caused by one single thing. It results from a combination of genetic vulnerability, immune system malfunction, and environmental triggers that set the process in motion. Here’s how each piece contributes.
The Immune System Turns on Your Own Skin
Vitiligo is fundamentally an autoimmune disease. Your body’s CD8+ T cells, a type of white blood cell designed to hunt down infections and abnormal cells, begin targeting healthy melanocytes as though they were threats. Research has shown that depleting these CD8+ T cells completely abolishes vitiligo in animal models, confirming they are the direct agents of destruction.
Once these immune cells lock onto melanocytes, they release inflammatory signaling molecules, particularly interferon-gamma and tumor necrosis factor-alpha. These signals recruit more immune cells to the area and amplify the attack. The melanocytes die off, and without them, your skin can no longer produce melanin in that spot. The result is a patch of completely depigmented skin.
What makes vitiligo persistent is that the immune system builds a lasting memory of this attack. The T cells responsible don’t burn out or become exhausted over time. Instead, they remain active and capable of rapidly responding again, which is why vitiligo patches can expand or new ones can appear months or years after the initial onset. This durable immune memory is also why vitiligo can be difficult to reverse: even when patches are treated successfully, the immune cells that caused them may still be circulating.
Genetics Load the Gun
You don’t inherit vitiligo directly, but you can inherit a predisposition to it. Researchers have identified multiple genes that increase susceptibility, many of which are involved in regulating the immune system. One well-studied gene, NLRP1, plays a role in your body’s innate immune response and inflammation. Variations in this gene have been significantly linked to vitiligo risk, especially when they interact with susceptibility signals on other chromosomes.
Another gene, FOXD3, located on chromosome 1, has also been tied to vitiligo and other autoimmune conditions. The pattern is telling: vitiligo susceptibility genes overlap heavily with genes linked to autoimmune thyroid disease, type 1 diabetes, and rheumatoid arthritis. This shared genetic architecture explains why vitiligo rarely travels alone.
Having a first-degree relative with vitiligo increases your risk, but most people with the genetic variants never develop the condition. Genetics create the vulnerability. Something else has to pull the trigger.
Triggers That Set It Off
For many people, vitiligo first appears after a specific event that stresses the skin or the body. One well-documented trigger is the Koebner phenomenon, where skin trauma causes new vitiligo patches to form at the site of injury. The types of trauma that can provoke this include cuts and surgical wounds, burns (including sunburns), tattoos and tattoo removal, insect bites, scratching, and even piercings. Any injury that penetrates through the top and middle layers of skin can potentially trigger it in someone who is susceptible.
Chemical exposure is another recognized trigger. Certain industrial chemicals, particularly phenol-based compounds found in some hair dyes, adhesives, and cleaning products, are known to be toxic to melanocytes. For people with the right genetic background, repeated contact with these substances can initiate the autoimmune cascade.
Severe emotional stress, illness, and hormonal changes have also been reported as triggers by patients, though these are harder to study in controlled settings. The common thread is that something disrupts the skin’s local environment or the body’s immune balance enough to expose melanocytes to immune attack.
Not All Vitiligo Works the Same Way
There are two main forms of vitiligo, and they develop through somewhat different pathways. Nonsegmental vitiligo is the more common type, accounting for the majority of cases. It produces symmetrical patches on both sides of the body and is driven primarily by the systemic autoimmune process described above. It tends to be progressive, with new patches appearing over time.
Segmental vitiligo behaves differently. It appears on only one side of the body, often follows a pattern that corresponds to nerve pathways or blood supply territories, and usually stabilizes early rather than continuing to spread. Recent research points to a combination of factors unique to this form: somatic mosaicism (a genetic change in a localized group of cells rather than the whole body), sympathetic nerve dysfunction in the affected area, and changes in the local immune environment driven by small RNA molecules. Segmental vitiligo also frequently involves hair follicles, turning hair in the affected area white, which is less common in nonsegmental cases.
Conditions That Travel With Vitiligo
Because vitiligo shares its genetic and immune roots with other autoimmune diseases, people with vitiligo have higher rates of several related conditions. Autoimmune thyroid disease, including both Hashimoto’s thyroiditis and Graves’ disease, is the most common companion. Type 1 diabetes, rheumatoid arthritis, lupus, and alopecia areata also appear at elevated rates. The underlying connection is a shared pattern of immune signaling, particularly a chemical messenger called CXCL10 that is elevated in many of these organ-specific autoimmune conditions.
Vitiligo also affects more than the skin. People with vitiligo face roughly six times the risk of developing sensorineural hearing loss compared to the general population. This makes sense biologically: melanocytes exist not only in skin but also in the inner ear and the eyes, where they play functional roles. When the immune system targets melanocytes broadly, these other sites can be affected too.
Psychological impact is significant as well. Visible depigmentation, especially on the face and hands, is strongly associated with anxiety, depression, and reduced quality of life, particularly in cultures where skin appearance carries heavy social weight.
How Vitiligo Is Identified
Diagnosis is usually clinical, meaning a dermatologist can often identify vitiligo by examining the skin. The patches have characteristic features: they are completely white (not just lighter than surrounding skin), have well-defined borders, and tend to appear in typical locations like the face, hands, wrists, and areas around body openings.
When the diagnosis isn’t immediately clear, a Wood’s lamp examination helps. This handheld ultraviolet light makes depigmented skin glow bright blue-white, which distinguishes true vitiligo from other conditions that merely lighten the skin. Your doctor will also consider your health history, family history of autoimmune disease, and whether the pattern is symmetrical or one-sided, since this determines the type and helps predict how it will behave over time.
Blood tests aren’t needed to diagnose vitiligo itself, but they’re often ordered to screen for associated conditions, particularly thyroid disease, given how frequently the two overlap.